Compounds > glucose tetrasaccharide
Page last updated: 2024-09-05

glucose tetrasaccharide and Glycogen Storage Disease Type II

glucose tetrasaccharide has been researched along with Glycogen Storage Disease Type II in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19901 (8.33)18.7374
1990's0 (0.00)18.2507
2000's4 (33.33)29.6817
2010's6 (50.00)24.3611
2020's1 (8.33)2.80

Authors

AuthorsStudies
de Boer, F; Derks, TGJ; Fokkert-Wilts, MJ; Heiner-Fokkema, MR; Hoogeveen, IJ; Maatman, RGHJ; van der Krogt, J1
Bobillo Lobato, J; Durán Parejo, P; Jiménez Jiménez, LM; Tejero Díez, P1
Ahmadipour, F; Aryani, O; Fani, S; Houshmand, M; Kamalidehghan, B; Khalili, E; Manshadi, MD; Tondar, M1
Bali, D; Corzo, D; Kishnani, PS; Millington, DS; Thurberg, BL; Young, SP; Zhang, H1
Bainbridge, K; Burke, D; Finnegan, N; Franses, R; Heales, S; Lam, A; Manwaring, V; Prunty, H; Vellodi, A1
Bali, D; Case, LE; Champion, M; Dimmock, D; Hershkovitz, E; Jones, SA; Kishnani, PS; Mendelsohn, NJ; Messinger, YH; Olson, R; Rhead, W; Rosenberg, AS; Wells, C; White, A; Young, SP1
Bali, DS; Bashir, MR; Goldstein, JL; Kishnani, PS; Laforet, P; Millington, DS; Piraud, M; Rehder, C; Young, SP; Zhang, H1
Higuchi, I; Kawano, Y; Maegaki, Y; Maruyama, S; Nanba, E; Narita, A; Ohno, K; Toyoshima, M; Yonee, C; Young, SP1
An, Y; Chen, YT; Millington, DS; Stevens, RD; Young, SP1
Amalfitano, A; An, Y; Chen, YT; Corz, D; Kishnani, PS; Millington, DS; Young, SP1
Chester, MA; Häger, A; Loonen, C; Lundblad, A; Sjöblad, S; Tager, JM; Zopf, D1
An, Y; Chen, YT; Hillman, SL; Millington, DS; Van Hove, JL; Young, SP1

Trials

2 trial(s) available for glucose tetrasaccharide and Glycogen Storage Disease Type II

ArticleYear
[Tetra-saccharide glucose as a diagnostic biomarker for Pompe disease: a study with 35 patients].
    Medicina clinica, 2013, Aug-04, Volume: 141, Issue:3

    Topics: Adolescent; Adult; Age of Onset; Area Under Curve; Biomarkers; Child; Child, Preschool; Chromatography, High Pressure Liquid; Female; Glycogen; Glycogen Storage Disease Type II; Humans; Infant; Male; Middle Aged; Oligosaccharides; ROC Curve; Young Adult

2013
Long-term monitoring of patients with infantile-onset Pompe disease on enzyme replacement therapy using a urinary glucose tetrasaccharide biomarker.
    Genetics in medicine : official journal of the American College of Medical Genetics, 2009, Volume: 11, Issue:7

    Topics: Alanine Transaminase; alpha-Glucosidases; Aspartate Aminotransferases; Biomarkers; Creatine Kinase; Glycogen; Glycogen Storage Disease Type II; Humans; Infant; Infant, Newborn; Monitoring, Physiologic; Muscle, Skeletal; Oligosaccharides; Tandem Mass Spectrometry

2009

Other Studies

10 other study(ies) available for glucose tetrasaccharide and Glycogen Storage Disease Type II

ArticleYear
The multiple faces of urinary glucose tetrasaccharide as biomarker for patients with hepatic glycogen storage diseases.
    Genetics in medicine : official journal of the American College of Medical Genetics, 2020, Volume: 22, Issue:11

    Topics: Biomarkers; Glycogen Storage Disease; Glycogen Storage Disease Type II; Humans; Liver; Oligosaccharides

2020
A newly identified c.1824_1828dupATACG mutation in exon 13 of the GAA gene in infantile-onset glycogen storage disease type II (Pompe disease).
    Molecular biology reports, 2014, Volume: 41, Issue:9

    Topics: alpha-Glucosidases; Cardiomyopathies; Consanguinity; Exons; Genetic Predisposition to Disease; Genome-Wide Association Study; Genome, Human; Genotype; Genotyping Techniques; Glucan 1,4-alpha-Glucosidase; Glycogen; Glycogen Storage Disease Type II; Humans; Infant; Iran; Male; Mutation; Oligosaccharides; Sequence Analysis, DNA

2014
Urine analysis of glucose tetrasaccharide by HPLC; a useful marker for the investigation of patients with Pompe and other glycogen storage diseases.
    Journal of inherited metabolic disease, 2012, Volume: 35, Issue:2

    Topics: Biomarkers; Child; Child, Preschool; Chromatography, High Pressure Liquid; Enzyme Replacement Therapy; Female; Glycogen Storage Disease; Glycogen Storage Disease Type II; Humans; Infant; Male; Middle Aged; Oligosaccharides

2012
Successful immune tolerance induction to enzyme replacement therapy in CRIM-negative infantile Pompe disease.
    Genetics in medicine : official journal of the American College of Medical Genetics, 2012, Volume: 14, Issue:1

    Topics: alpha-Glucosidases; Antibodies; B-Lymphocytes; Enzyme Replacement Therapy; Female; Glycogen Storage Disease Type II; Humans; Immune Tolerance; Infant; Infant, Newborn; Magnetic Resonance Imaging; Male; Neuroimaging; Oligosaccharides; Recombinant Proteins; Treatment Outcome

2012
Assessing disease severity in Pompe disease: the roles of a urinary glucose tetrasaccharide biomarker and imaging techniques.
    American journal of medical genetics. Part C, Seminars in medical genetics, 2012, Feb-15, Volume: 160C, Issue:1

    Topics: Adult; Age Factors; Aged; alpha-Glucosidases; Biomarkers; Child; Child, Preschool; Diagnostic Imaging; Disease Progression; Enzyme Replacement Therapy; Glycogen; Glycogen Storage Disease Type II; Humans; Infant; Infant, Newborn; Middle Aged; Muscle, Skeletal; Mutation; Oligosaccharides; Prognosis; Sequence Analysis, DNA; Treatment Outcome; Young Adult

2012
Quantitative computed tomography for enzyme replacement therapy in Pompe disease.
    Brain & development, 2012, Volume: 34, Issue:10

    Topics: alpha-Glucosidases; Child, Preschool; Enzyme Replacement Therapy; Female; Glycogen; Glycogen Storage Disease Type II; Humans; Liver; Muscle, Skeletal; Oligosaccharides; Tomography, X-Ray Computed

2012
Analysis of a glucose tetrasaccharide elevated in Pompe disease by stable isotope dilution-electrospray ionization tandem mass spectrometry.
    Analytical biochemistry, 2003, May-15, Volume: 316, Issue:2

    Topics: Biomarkers; Calibration; Carbohydrate Sequence; Carbon Isotopes; Chromatography, High Pressure Liquid; Glycogen Storage Disease Type II; Humans; Indicator Dilution Techniques; Molecular Sequence Data; Oligosaccharides; Reference Standards; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization

2003
Glucose tetrasaccharide as a biomarker for monitoring the therapeutic response to enzyme replacement therapy for Pompe disease.
    Molecular genetics and metabolism, 2005, Volume: 85, Issue:4

    Topics: alpha-Amylases; alpha-Glucosidases; Biomarkers; Case-Control Studies; Glucan 1,4-alpha-Glucosidase; Glycogen; Glycogen Storage Disease Type II; Humans; Monitoring, Physiologic; Oligosaccharides

2005
Increased urinary excretion of a glycogen-derived tetrasaccharide in heterozygotes with glycogen storage diseases type II and III.
    Lancet (London, England), 1983, Apr-30, Volume: 1, Issue:8331

    Topics: Adult; Aged; Child; Child, Preschool; Female; Glycogen Storage Disease; Glycogen Storage Disease Type II; Glycogen Storage Disease Type III; Heterozygote; Humans; Male; Middle Aged; Oligosaccharides

1983
Liquid chromatographic assay for a glucose tetrasaccharide, a putative biomarker for the diagnosis of Pompe disease.
    Analytical biochemistry, 2000, Dec-01, Volume: 287, Issue:1

    Topics: Adolescent; Adult; Biomarkers; Child; Child, Preschool; Chromatography, High Pressure Liquid; Chromatography, Liquid; Female; Glycogen Storage Disease Type II; Humans; Infant; Male; Middle Aged; Oligosaccharides; Sensitivity and Specificity

2000